YVETTE HOLMAN: Open Payments
NPI 1205254125 · HAWAIIAN GARDENS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,627 in 169 payments from 21 companies in 2025. Trend: 2023 $3,175 · 2024 $3,978 · 2025 $4,627
Food & beverage: $4,627
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $667 |
| Vanda Pharmaceuticals Inc. | 25 | $585 |
| Alkermes, Inc. | 12 | $456 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $455 |
| Otsuka America Pharmaceutical, Inc. | 15 | $433 |
| Lundbeck LLC | 18 | $310 |
| Axsome Therapeutics, Inc. | 14 | $283 |
| E.R. Squibb & Sons, L.L.C. | 8 | $263 |
| Teva Pharmaceuticals USA, Inc. | 11 | $219 |
| Janssen Pharmaceuticals, Inc | 6 | $212 |
Products named: VRAYLAR, FANAPT, CAPLYTA, REXULTI, ARISTADA, Auvelity, UZEDY, COBENFY.
Industry payments across CA — which companies pay providers there.
